Interleukin-17 Mediated Differences in the Pathogenesis of HIV-1-associated Tuberculous and Cryptococcal Meningitis

AIDS - United States
doi 10.1097/qad.0000000000000904
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Emerging Concepts in HIV-associated Cryptococcal Meningitis

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2019English

Recent Advances in Managing HIV-associated Cryptococcal Meningitis

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Factors Associated With Early Mycological Clearance in HIV-associated Cryptococcal Meningitis

PLoS ONE
Multidisciplinary
2017English

HIV-1 Drug Resistance in Antiretroviral-Naive Individuals With HIV-1-associated Tuberculous Meningitis Initiating Antiretroviral Therapy in Vietnam

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Risk Factors in HIV/AIDS Patients With Cryptococcal Meningitis

BMC Infectious Diseases
Infectious Diseases
2014English

HIV-1 Nef in Macrophage-Mediated Disease Pathogenesis

International Reviews of Immunology
AllergyImmunology
2012English

The Use of Mannitol in HIV-infected Patients With Symptomatic Cryptococcal Meningitis

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2016English

Ophthalmic Signs in Ugandan Adults With HIV-associated Cryptococcal Meningitis: A Nested Analysis of the ASTRO-CM Cohort

Wellcome Open Research
BiochemistryMedicineGeneticsMolecular Biology
2018English

Influence of Antituberculosis Drug Resistance and Mycobacterium Tuberculosis Lineage on Outcome in HIV-Associated Tuberculous Meningitis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy